Mostrar el registro sencillo del ítem

dc.contributor.authorPech-Puch, D.
dc.contributor.authorForero Tunjano, Abel Mateo
dc.contributor.authorFuentes Monteverde, Juan Carlos de la Cruz
dc.contributor.authorLasarte Monterrubio, Cristina
dc.contributor.authorMartinez Guitian, Marta
dc.contributor.authorGonzález-Salas, C.
dc.contributor.authorGuillén-Hernández, S.
dc.contributor.authorVillegas-Hernández, H.
dc.contributor.authorBeceiro Casas, Alejandro
dc.contributor.authorGriesinger, C.
dc.contributor.authorRodríguez González, Jaime
dc.contributor.authorJiménez González, Carlos
dc.date.accessioned2025-08-25T12:43:51Z
dc.date.available2025-08-25T12:43:51Z
dc.date.issued2022
dc.identifier.citationPech-Puch D, Forero AM, Fuentes-Monteverde JC, Lasarte-Monterrubio C, Martinez-Guitian M, González-Salas C, et al. Antimicrobial Diterpene Alkaloids from an Agelas citrina Sponge Collected in the Yucatán Peninsula. Marine Drugs. 2022;20(5).
dc.identifier.issn1660-3397
dc.identifier.otherhttps://portalcientifico.sergas.gal/documentos/629a6b4499388161baf40ef4*
dc.identifier.urihttp://hdl.handle.net/20.500.11940/20519
dc.description.abstractThree new diterpene alkaloids, (+)-8-epiagelasine T (1), (+)-10-epiagelasine B (2), and (+)-12-hydroxyagelasidine C (3), along with three known compounds, (+)-ent-agelasine F (4), (+)-agelasine B (5), and (+)-agelasidine C (6), were isolated from the sponge Agelas citrina, collected on the coasts of the Yucatán Peninsula (Mexico). Their chemical structures were elucidated by 1D and 2D NMR spectroscopy, HRESIMS techniques, and a comparison with literature data. Although the synthesis of (+)-ent-agelasine F (4) has been previously reported, this is the first time that it was isolated as a natural product. The evaluation of the antimicrobial activity against the Gram-positive pathogens Staphylococcus aureus, Streptococcus pneumoniae, Enterococcus faecalis showed that all of them were active, with (+)-10-epiagelasine B (2) being the most active compound with an MIC in the range of 1-8 µg/mL. On the other hand, the Gram-negative pathogenes Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae were also evaluated, and only (+)-agelasine B (5) showed a moderate antibacterial activity with a MIC value of 16 µg/mL.en
dc.description.sponsorshipThis work was supported by grants RTI2018-093634-B-C22 from the State Agency for Research (AEI) of Spain, cofunded by the FEDER Programme from the European Union (MCIN/AEI/10.13039/501100011033/FEDER) and BLUEBIOLAB (0474_BLUEBIOLAB_1_E), Programme INTER-REG V A of Spain-Portugal (POCTEP). This work was supported by Projects PI17/01482 and PI20/01212 awarded to AB, all within in the National Plan for Scientific Research, Development and Technological Innovation 2017-2020 and funded by the ISCIII-General Subdirection of Assessment and Promotion of the Research-European Regional Development Fund (FEDER) A way of making Europe. The work was also supported by CIBERINFEC (CIBER de Enfermedades Infecciosas). The study was also funded by project IN607D 2021/12 (GAIN-Agencia Gallega de InnovacionConselleria de Economia, Emprego e Industria) awarded to AB. The study was also funded by projects GRC2018/039 from Xunta de Galicia. Dawrin Pech-Puch received his postdoctoral fellowship from the National Council of Science and Technology (CONACYT) of Mexico. This work was supported by the Max Planck Society and the DFG (Gr1211/19-1)/CAPES 418729698 project.en
dc.language.isoeng
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.titleAntimicrobial Diterpene Alkaloids from an Agelas citrina Sponge Collected in the Yucatán Peninsula*
dc.typeArticleen
dc.authorsophosPech-Puch, C. D.
dc.authorsophosForero, A. M.
dc.authorsophosFuentes-Monteverde, J. C.
dc.authorsophosLasarte-Monterrubio, C.
dc.authorsophosMartinez-Guitian, M.
dc.authorsophosGonzález-Salas, C.
dc.authorsophosGuillén-Hernández, S.
dc.authorsophosVillegas-Hernández, H.
dc.authorsophosBeceiro, A.
dc.authorsophosGriesinger, C.
dc.authorsophosRodríguez, J.
dc.authorsophosJiménez
dc.identifier.doi10.3390/md20050298
dc.identifier.sophos629a6b4499388161baf40ef4
dc.issue.number5
dc.journal.titleMarine Drugs*
dc.page.initialnull
dc.relation.projectIDState Agency for Research (AEI) of Spain [RTI2018-093634-B-C22]; FEDER Programme from the European Union (MCIN/AEI/FEDER); BLUEBIOLAB [0474_BLUEBIOLAB_1_E]; Programme INTER-REG V A of Spain-Portugal (POCTEP); National Plan for Scientific Research, Development and Technological Innovation 2017-2020 [PI17/01482, PI20/01212]; ISCIII-General Subdirection of Assessment and Promotion of the Research-European Regional Development Fund (FEDER) A way of making Europe; CIBERINFEC (CIBER de Enfermedades Infecciosas); GAIN-Agencia Gallega de InnovacionConselleria de Economia, Emprego e Industria [IN607D 2021/12]; Xunta de Galicia [GRC2018/039]; National Council of Science and Technology (CONACYT) of Mexico; Max Planck Society; DFG [(Gr1211/19-1)/CAPES 418729698]
dc.relation.publisherversionhttps://publications.goettingen-research-online.de/bitstream/2/108613/1/document.pdf;https://mdpi-res.com/d_attachment/marinedrugs/marinedrugs-20-00298/article_deploy/marinedrugs-20-00298-v2.pdf?version=1651210949es
dc.rights.accessRightsopenAccess
dc.subject.keywordINIBICes
dc.subject.keywordAS Coruñaes
dc.subject.keywordCHUACes
dc.typefidesArtículo Científico (incluye Original, Original breve, Revisión Sistemática y Meta-análisis)es
dc.typesophosArtículo Originales
dc.volume.number20


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución 4.0 Internacional